SciClone Pharmaceuticals Overview

  • Year Founded
  • 1990

Year Founded

  • Status
  • Private

  • Employees
  • 1,046

Employees

  • Latest Deal Type
  • Fund - Cont Trans

  • Financing Rounds
  • 9

  • Investments
  • 2

SciClone Pharmaceuticals General Information

Description

SciClone Pharmaceuticals (Holdings) Ltd is a biopharmaceutical company with an integrated platform for product development and commercialization. It strategically focuses on some of the fast-growing therapeutic areas with unmet medical needs in China, including oncology and severe infection. Its products are Zadaxin, Zometa, Oravig, Endoxan, Angiomax, and others. It derives revenue from sales of products.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 22F, Central Plaza
  • 381 Middle Huaihai Road
  • Shanghai
  • China
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 22F, Central Plaza
  • 381 Middle Huaihai Road
  • Shanghai
  • China

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SciClone Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore SciClone Pharmaceuticals‘s full profile, request access.

Request a free trial

SciClone Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
SciClone Pharmaceuticals (Holdings) Ltd is a biopharmaceutical company with an integrated platform for product developme
Drug Discovery
Shanghai, China
1,046 As of 2023

Cambridge, MA
 

Germantown, MD
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

SciClone Pharmaceuticals Competitors (29)

One of SciClone Pharmaceuticals’s 29 competitors is VBI Vaccines, a Corporation company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
VBI Vaccines Corporation Cambridge, MA
Precigen Formerly VC-backed Germantown, MD
ImmunityBio Formerly VC-backed San Diego, CA
Dynavax Technologies Formerly VC-backed Emeryville, CA
Bristol-Myers Squibb Corporation Princeton, NJ
You’re viewing 5 of 29 competitors. Get the full list »

SciClone Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SciClone Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore SciClone Pharmaceuticals‘s full profile, request access.

Request a free trial

SciClone Pharmaceuticals Investments & Acquisitions (2)

SciClone Pharmaceuticals’s most recent deal was a Later Stage VC with Tarveda Therapeutics for . The deal was made on 27-Sep-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Tarveda Therapeutics 27-Sep-2021 Later Stage VC Drug Discovery
NovaMed Pharmaceuticals 19-Apr-2011 Merger/Acquisition Distributors (Healthcare)
To view SciClone Pharmaceuticals’s complete investments and acquisitions history, request access »

SciClone Pharmaceuticals Exits (1)

SciClone Pharmaceuticals’s most recent exit was on 27-Sep-2021 from Tarveda Therapeutics. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Tarveda Therapeutics 27-Sep-2021 Completed
To view SciClone Pharmaceuticals’s complete exits history, request access »

SciClone Pharmaceuticals FAQs

  • When was SciClone Pharmaceuticals founded?

    SciClone Pharmaceuticals was founded in 1990.

  • Where is SciClone Pharmaceuticals headquartered?

    SciClone Pharmaceuticals is headquartered in Shanghai, China.

  • What is the size of SciClone Pharmaceuticals?

    SciClone Pharmaceuticals has 1,046 total employees.

  • What industry is SciClone Pharmaceuticals in?

    SciClone Pharmaceuticals’s primary industry is Drug Discovery.

  • Is SciClone Pharmaceuticals a private or public company?

    SciClone Pharmaceuticals is a Private company.

  • What is SciClone Pharmaceuticals’s current revenue?

    The current revenue for SciClone Pharmaceuticals is .

  • How much funding has SciClone Pharmaceuticals raised over time?

    SciClone Pharmaceuticals has raised $281M.

  • Who are SciClone Pharmaceuticals’s investors?

    Bosera Capital, Bradbury Asset Management, China Post Fund, IDG Capital, and Shanghai Dazhong Public Utilities Group are 5 of 10 investors who have invested in SciClone Pharmaceuticals.

  • Who are SciClone Pharmaceuticals’s competitors?

    VBI Vaccines, Precigen, ImmunityBio, Dynavax Technologies, and Bristol-Myers Squibb are some of the 29 competitors of SciClone Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process